No Data
Fuji Pharma: Notice regarding the 60th anniversary dividend and dividend forecast for the fiscal year ending 2025/9
Fuji Pharma: Summary of Financial Results for the Fiscal Year Ending 2024/9 [Japanese GAAP] (Consolidated)
Daiwa House, Idemitsu Kosan, Tokyo Electron Ltd. unsponsored adr, SoftBank Group (12th)
※Please note that the above calendar is subject to change depending on the company's circumstances. --------------------------------------- November 12 (Tuesday) ＜1431＞ Livework ＜146A＞ Colombia ＜148A＞ Hatchwork ＜1491＞ Chugai Mining ＜1605＞ INPEX ＜1663＞ K&O Energy ＜166A＞ Taski HD ＜1770＞ Fujita E
Fuji Pharma To Go Ex-Dividend On September 27th, 2024 With 22.5 JPY Dividend Per Share
September 26th (Japan Standard Time) - $Fuji Pharma(4554.JP)$ is trading ex-dividend on September 27th, 2024.Shareholders of record on September 30th, 2024 will receive 22.5 JPY dividend per share.
Volume change rate ranking (9am) - RepliCel, Fujifilm Pharmaceuticals, etc. ranked in.
In the volume change rate ranking, by comparing the volume of the last 5 days with the volume on the delivery day, market participants can understand the trend of the market's interest. Top volume change rate [as of August 19, 9:32am] (compared to the average volume of the last 5 days): stock code, stock name, volume, 5-day average volume, volume change rate, and stock price change rate. <2389> Digital HD, 377200, 107185.08, 241.5%, 0% <488>
Mitsui Sumitomo Construction, Sata Construction, and others.
<1821> Sumitomo Mitsui Construction Co., Ltd. Nana Aoyama Real Estate Co., Ltd. shareholding ratio 12.54% → 13.80%. Reporting obligation start date: August 5, 2024. <1826> Sata Construction Co., Ltd. UGS Asset Management Co., Ltd. shareholding ratio 9.33% → 10.65%. Reporting obligation start date: August 5, 2024. <1982> Hibiya Comprehensive Facility Co., Ltd. KDDI Communications Co., Ltd. shareholding ratio 5.01% → 6.03%. Reporting obligation.
No Data
No Data